The role is directly responsible for implementing the brand strategy within the Nordic region. This will include development and execution of healthcare professional and marketing initiatives, insights development and messaging, sales support and PR, aligned to the regional strategy.
The position is core to the commercial team in the cluster and will play a key role in development of business strategy and the launch of future products.
Support launch initiatives for new products in conjunction with the commercial, market access and medical team.
Minimum 5 years Marketing/commercial experience with evidence of achievement in the healthcare or pharmaceutical marketplace. You are motivated by operating independently with strong project management skills, able to deliver projects on time.
Entrepreneurial, financially & commercially astute with clear link to numbers of activities is crucial and obviously you have strong interpersonal skills – inspiring the cross functional team.
In this recruitment Indivior is cooperating with Compass Human Resources Group. If you want more information please contact Anders Larsson at firstname.lastname@example.org +46 73 203 4691 or Jens Nordqvist at email@example.com +46 70 145 35 69
Indivior is a global specialty pharmaceutical company with a 20-year legacy of leadership in patient advocacy, health policy and evidence-based best practice models that have revolutionized modern addiction treatment. The name is the blend of the words individual and endeavor, and the tagline “Focus on you” makes the company’s commitment clear. It represents and empathizes with the often-difficult journey each individual patient takes to overcome the challenges of addiction – a chronic relapsing disease.
Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. The Indivior logo radiates its patient-focused, holistic focus on expanding access to quality treatment for addiction worldwide. The company has a strong pipeline of products and candidates designed to both expand on its heritage in global opioid dependence and address other chronic diseases of addiction – including opiate overdose, alcohol use disorders and cocaine intoxication – as well as related mental health disorders such as schizophrenia.